Previous 10 | Next 10 |
Stealth BioTherapeutics Announces Elamipretide Clinical Data to be Presented at the 13th International Conference on Cachexia, Sarcopenia and Wasting Diseases BOSTON , Dec. 9, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotech...
Stealth BioTherapeutics Announces Appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors BOSTON , Dec. 7, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and co...
Stealth BioTherapeutics Announces Closing of $3.2 Million Registered Direct Offering PR Newswire BOSTON, Nov. 24, 2020 BOSTON , Nov. 24, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage ...
Gainers: Kaixin Auto (KXIN) +104%.FTS International (FTSI) +44%.Ayro (AYRO) +42%.Blink Charging (BLNK) +31%.Dada Nexus (DADA) +30%.Ideanomics (IDEX) +23%.Ra Medical Systems (RMED) +22%.SPI Energy (SPI) +21%.Canaan (CAN) +20%.Longview Acquisition (LGVW) +20%.Losers: Tantech (TAN...
Gainers: Titan Pharmaceuticals (TTNP) +31%, Idera Pharmaceuticals (IDRA) +27%, Mesoblast (MESO) +20%, 22nd Century Group (XXII) +14%, Genfit (GNFT) +13%.Losers: AVROBIO (AVRO) -14%, Stealth BioTherapeutics (MITO) -14%, Kazia Therapeu...
Nano Dimension (NNDM) -28% after prices $100M registered direct offering.Euroseas (ESEA) -23% on Q3 earnings release.GSX Techedu (GSX) -16% on Q3 earnings release.Stealth BioTherapeutics (MITO) -13% on launch of $3.2M registered direct offering.Arcimoto...
Stealth BioTherapeutics (MITO) inks securities purchase agreements with institutional investors to purchase 2,844,446 of its ADSs in a registered direct offering. The purchase price is $1.125/ADS.Expected gross proceeds are ~$3.2M.H.C. Wainwright & Co. is acting as the exclusive plac...
Stealth BioTherapeutics Announces $3.2 Million Registered Direct Offering PR Newswire BOSTON, Nov. 20, 2020 BOSTON , Nov. 20, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage biotechnolo...
Greenland Technologies Holding (GTEC) +88% on launching integrated electric drivetrain.Trxade Group (MEDS) +70%.Summit Wireless Technologies (WISA) +42% on Q4 guidance.Mogo (MOGO) +27% on Q3 results.Fulgent Genetics (FLGT) +16% on Q3 results.Affime...
Stealth BioTherapeutics, Inc. (MITO) Q3 2020 Earnings Conference Call November 05, 2020 08:30 AM EST Executives Henry Hess - CLC Reenie McCarthy - CEO Rob Weiskopf - CFO Jim Carr - CCDO Brian Blakey - CCO Analysts Charles Duncan - Cantor Fitzgerald Yi Chen - H.C. Wainwright Presentation Opera...
News, Short Squeeze, Breakout and More Instantly...
Stealth BioTherapeutics Corp. Company Name:
MITO Stock Symbol:
NYSE Market:
Stealth BioTherapeutics Corp. Website:
Stealth BioTherapeutics Corp Announces Completion of Merger PR Newswire BOSTON , Nov. 16, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the ...
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire SBT-272 Phase 1 safety and tolerability data support further clinical development SBT-272 was neuroprotective...
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders PR Newswire BOSTON , Oct. 7, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage biotechnology company focused o...